Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$304.11 - $351.99 $760,275 - $879,975
2,500 New
2,500 $864,000
Q3 2023

Nov 15, 2023

SELL
$350.25 - $422.63 $140,100 - $169,052
-400 Reduced 28.57%
1,000 $358,000
Q2 2023

Aug 23, 2023

BUY
$359.49 - $486.4 $179,745 - $243,200
500 Added 55.56%
1,400 $530,000
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $376,821 - $452,700
900 New
900 $425,000
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $231,835 - $298,580
500 New
500 $248,000
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $921,492 - $1.03 Million
-1,300 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $855,023 - $1.07 Million
1,300 New
1,300 $974,000
Q2 2021

Aug 06, 2021

SELL
$576.64 - $649.04 $1.15 Million - $1.3 Million
-2,000 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $109,402 - $132,470
200 Added 11.11%
2,000 $1.13 Million
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $306,408 - $386,070
600 Added 50.0%
1,800 $1.04 Million
Q3 2020

Nov 13, 2020

SELL
$454.43 - $535.6 $499,873 - $589,160
-1,100 Reduced 47.83%
1,200 $618,000
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $937,636 - $1.38 Million
-2,800 Reduced 54.9%
2,300 $994,000
Q1 2020

May 11, 2020

BUY
$320.01 - $409.07 $1.31 Million - $1.68 Million
4,100 Added 410.0%
5,100 $1.78 Million
Q4 2019

Feb 12, 2020

SELL
$319.73 - $374.2 $255,784 - $299,360
-800 Reduced 44.44%
1,000 $370,000
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $213,185 - $241,668
700 Added 63.64%
1,800 $601,000
Q2 2019

Aug 20, 2019

SELL
$286.93 - $312.59 $1.81 Million - $1.97 Million
-6,300 Reduced 85.14%
1,100 $344,000
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $1.23 Million - $1.75 Million
5,500 Added 289.47%
7,400 $2.26 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $418,190 - $587,100
1,900 New
1,900 $436,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.88B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.